Predictors of outcome in chronic thromboembolic pulmonary hypertension

被引:235
作者
Bonderman, Diana
Skoro-Sajer, Nika
Jakowitsch, Johannes
Adlbrecht, Christopher
Dunkler, Daniela
Taghavi, Sharokh
Klepetko, Walter
Kneussl, Meinhard
Lang, Irene M.
机构
[1] Med Univ Vienna, Dept Cardiol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Core Unit Med Stat & Informat, A-1090 Vienna, Austria
[3] Med Univ Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria
[4] Wilhelminenspital Stadt Wien, Dept Pulmonol, Vienna, Austria
关键词
hypertension; pulmonary; survival; thrombosis;
D O I
10.1161/CIRCULATIONAHA.106.661041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Chronic thromboembolic pulmonary hypertension ( CTEPH) is characterized by intraluminal thrombus organization and fibrous obliteration of pulmonary arteries. Recently, associated medical conditions such as splenectomy, ventriculoatrial shunt for the treatment of hydrocephalus, permanent central intravenous lines, inflammatory bowel disease, and osteomyelitis were found to be associated with the development of CTEPH. The study aim was to define the impact of these novel risk factors on survival. Methods and Results - Between January 1992 and December 2006, 181 patients diagnosed with CTEPH were tracked with the use of our center's customized computer database. A Cox regression model was used to examine relations between survival and associated medical conditions, age, sex, hemodynamic parameters, modified New York Heart Association functional class at diagnosis, CTEPH type, pulmonary endarterectomy, and anti-cardiolipin antibodies/lupus anticoagulant. During a median observation time of 22.1 ( range, 0.03 to 152) months, the clinical end point of cardiovascular death or lung transplantation occurred in 48 cases ( 27%). Pulmonary endarterectomy ( hazard ratio, 0.14; 95% CI, 0.05 to 0.41; P=0.0003), associated medical conditions ( hazard ratio, 3.17; 95% CI, 1.70 to 5.92; P=0.0003), and pulmonary vascular resistance ( hazard ratio, 1.02; 95% CI, 1.00 to 1.04; P=0.04) were predictors of survival. Thirty-day postoperative mortality ( 24% versus 9%) and the incidence of postoperative pulmonary hypertension ( 92% versus 20%) were substantially higher in patients with associated medical conditions. Conclusions - CTEPH-predisposing medical conditions, such as splenectomy, permanent central intravenous lines, and certain inflammatory disorders, predict poor survival in CTEPH.
引用
收藏
页码:2153 / 2158
页数:6
相关论文
共 21 条
[1]   Long-term outcome after pulmonary thromboendarterectomy [J].
Archibald, CJ ;
Auger, WR ;
Fedullo, PF ;
Channick, RN ;
Kerr, KM ;
Jamieson, SW ;
Kapelanski, DP ;
Watt, CN ;
Moser, KM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :523-528
[2]   Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension [J].
Bonderman, D ;
Jakowitsch, J ;
Adlbrecht, C ;
Schemper, M ;
Kyrle, PA ;
Schönauer, V ;
Exner, M ;
Klepetko, E ;
Kneussl, MR ;
Maurer, G ;
Lang, I .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) :512-516
[3]   High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension [J].
Bonderman, D ;
Turecek, PL ;
Jakowitsch, J ;
Weltermann, A ;
Adlbrecht, C ;
Schneider, B ;
Kneussl, M ;
Rubin, LJ ;
Kyrle, PA ;
Klepetko, W ;
Maurer, G ;
Lang, IM .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (03) :372-376
[4]   Inflammation in pulmonary arterial hypertension [J].
Dorfmüller, P ;
Perros, F ;
Balabanian, K ;
Humbert, M .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :358-363
[5]   Current concepts: Chronic thromboembolic pulmonary hypertension [J].
Fedullo, PF ;
Auger, WR ;
Kerr, KM ;
Rubin, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) :1465-1472
[6]   Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology [J].
Galiè, N ;
Torbicki, A ;
Barst, R ;
Dartevelle, P ;
Haworth, S ;
Higenbottam, T ;
Olschewski, H ;
Peacock, A ;
Pietra, G ;
Rubin, LJ ;
Simonneau, G .
EUROPEAN HEART JOURNAL, 2004, 25 (24) :2243-2278
[7]   Chronic thromboembolic pulmonary hypertension [J].
Hoeper, MM ;
Mayer, E ;
Simonneau, G ;
Rubin, LJ .
CIRCULATION, 2006, 113 (16) :2011-2020
[8]   Splenectomy and chronic thromboembolic pulmonary hypertension [J].
Jaïs, X ;
Ioos, V ;
Jardim, C ;
Sitbon, O ;
Parent, F ;
Hamid, A ;
Fadel, E ;
Dartevelle, P ;
Simonneau, G ;
Humbert, M .
THORAX, 2005, 60 (12) :1031-1034
[9]   Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases [J].
Jamieson, SW ;
Kapelanski, DP ;
Sakakibara, N ;
Manecke, GR ;
Thistlethwaite, PA ;
Kerr, KM ;
Channick, RN ;
Fedullo, PF ;
Auger, WR .
ANNALS OF THORACIC SURGERY, 2003, 76 (05) :1457-1462
[10]   Pulmonary thromboendarterectomy [J].
Jamieson, SW .
HEART, 1998, 79 (02) :118-120